Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 21.4.2022ratiopharm GmbH (RAT)37718Moxonidin-ratiopharm 0,4 mg (tbl flm 100x0,4 mg (blis.PVC/PVDC/Al))29.4.2022O
 21.4.2022ratiopharm GmbH (RAT)51662Perindocombi 4 mg/1,25 mg (tbl 90x4 mg/1,25 mg (blis.PA/Al/PVC/Al))29.4.2022R
 21.4.2022ratiopharm GmbH (RAT)69884Indapamid ratiopharm 1,5 mg (tbl plg 30x1,5 mg (blister PVC/PVDc/Al))29.4.2022O
 20.4.2022KRKA, d.d., Novo mesto (KRK-2)0961BSobycombi 5 mg/5 mg tablety (tbl 90x5 mg/5 mg (blis.OPA/Al/PVC/Al))6.6.2022R
 20.4.2022KRKA, d.d., Novo mesto (KRK-2)20488Tolura 40 mg tablety (tbl 28x40 mg (blis.OPA/Al/PVC/Al))9.5.2022R
 20.4.2022Mylan Ireland Limited (MNY)50490Ciclosporin Mylan 25 mg (cps mol 50x25 mg (blis. Al/Al))22.4.2022R
 20.4.2022Belupo lijekovi i kozmetika d.d. (BEU)7087CMIDZA 50 mg filmom obalené tablety (tbl flm 56x50 mg (blis.PVC/PVDC/Al))22.4.2022O
 20.4.2022Zentiva, k.s. (ZNT-1)2504DZetovar 10 mg/10 mg tablety (tbl 30x10 mg/10 mg (blis.OPA/Al/PVC))21.4.2022O
 20.4.2022Zentiva, k.s. (ZNT-1)2509DZetovar 10 mg/20 mg tablety (tbl 90x10 mg/20 mg (blis.OPA/Al/PVC))20.4.2022R
 20.4.2022Zentiva, k.s. (ZNT-1)5327BZenaro 5 mg (tbl flm 50x5 mg (blis.PVC/PE/PVDC/Al))21.4.2022O
 20.4.2022GlaxoSmithKline Biologicals S.A. (GAG)69867Synflorix injekčná suspenzia v naplnenej injekčnej striekačke (sus inj 10x0,5 ml (10 napl.inj.striek. + 10 ihiel))15.3.2022R
 20.4.2022GlaxoSmithKline Vaccines S.r.I. (GAG-IT)4431ABexsero injekčná suspenzia v naplnenej injekčnej striekačke, Vakcína proti meningokokom skupiny B (rDNA, zložková, adsorbovaná) (sus inj 1x0,5 ml (striek.inj.napl.skl.+ihla))15.3.2022R
 20.4.2022Novo Nordisk A/S (NOO)1679DNorditropin NordiFlex 10 mg/1,5 ml (sol ira 1x1,5 ml (náplň skl.v napl.inj.pere))19.4.2022R
 20.4.2022GlaxoSmithKline (Ireland) Limited (GAG-IE-2)02085Zeffix 100 mg filmom obalené tablety (tbl flm 28x100 mg (blis.Al/PVC))3.3.2022O
 20.4.2022GlaxoSmithKline (Ireland) Limited (GAG-IE-2)13971Flixotide 50 Inhaler N (sus inh 1x120 dávok (nád.tlak.Al))17.3.2022O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)